| Product Code: ETC319636 | Publication Date: Aug 2022 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Czech Republic`s import trend for colistin in the Czech Republic market experienced a notable decline from 2023 to 2024, with a growth rate of -26.38%. The compound annual growth rate (CAGR) for the period 2020-2024 stood at -16.94%. This downward trajectory could be attributed to shifts in demand dynamics or regulatory changes impacting market stability.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Czech Republic Colistin Market Overview |
3.1 Czech Republic Country Macro Economic Indicators |
3.2 Czech Republic Colistin Market Revenues & Volume, 2021 & 2031F |
3.3 Czech Republic Colistin Market - Industry Life Cycle |
3.4 Czech Republic Colistin Market - Porter's Five Forces |
3.5 Czech Republic Colistin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Czech Republic Colistin Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Czech Republic Colistin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antibiotic-resistant infections in the Czech Republic |
4.2.2 Growing awareness about the effectiveness of colistin in treating multidrug-resistant bacterial infections |
4.2.3 Rising investments in healthcare infrastructure and facilities in the country |
4.3 Market Restraints |
4.3.1 Stringent regulations and restrictions on the use of colistin due to its potential side effects and contribution to antibiotic resistance |
4.3.2 High cost associated with the development and production of colistin-based medications |
5 Czech Republic Colistin Market Trends |
6 Czech Republic Colistin Market, By Types |
6.1 Czech Republic Colistin Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Czech Republic Colistin Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Czech Republic Colistin Market Revenues & Volume, By API, 2021 - 2031F |
6.1.4 Czech Republic Colistin Market Revenues & Volume, By Premix, 2021 - 2031F |
6.1.5 Czech Republic Colistin Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Czech Republic Colistin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Czech Republic Colistin Market Revenues & Volume, By Pig, 2021 - 2031F |
6.2.3 Czech Republic Colistin Market Revenues & Volume, By Chicken, 2021 - 2031F |
6.2.4 Czech Republic Colistin Market Revenues & Volume, By Other, 2021 - 2031F |
7 Czech Republic Colistin Market Import-Export Trade Statistics |
7.1 Czech Republic Colistin Market Export to Major Countries |
7.2 Czech Republic Colistin Market Imports from Major Countries |
8 Czech Republic Colistin Market Key Performance Indicators |
8.1 Percentage increase in the number of reported cases of antibiotic-resistant infections in the Czech Republic |
8.2 Adoption rate of colistin as a treatment option for multidrug-resistant bacterial infections in healthcare facilities |
8.3 Investment flow into research and development of alternative antibiotics to colistin |
8.4 Percentage of healthcare professionals trained in the appropriate use of colistin and antibiotic stewardship practices |
8.5 Number of clinical trials and studies evaluating the efficacy and safety of colistin in the Czech Republic |
9 Czech Republic Colistin Market - Opportunity Assessment |
9.1 Czech Republic Colistin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Czech Republic Colistin Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Czech Republic Colistin Market - Competitive Landscape |
10.1 Czech Republic Colistin Market Revenue Share, By Companies, 2024 |
10.2 Czech Republic Colistin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |